Drosophila appear resistant to trans-synaptic tau propagation
- PMID: 39130515
- PMCID: PMC11316205
- DOI: 10.1093/braincomms/fcae256
Drosophila appear resistant to trans-synaptic tau propagation
Abstract
Alzheimer's disease is the most common cause of dementia in the elderly, prompting extensive efforts to pinpoint novel therapeutic targets for effective intervention. Among the hallmark features of Alzheimer's disease is the development of neurofibrillary tangles comprised of hyperphosphorylated tau protein, whose progressive spread throughout the brain is associated with neuronal death. Trans-synaptic propagation of tau has been observed in mouse models, and indirect evidence for tau spread via synapses has been observed in human Alzheimer's disease. Halting tau propagation is a promising therapeutic target for Alzheimer's disease; thus, a scalable model system to screen for modifiers of tau spread would be very useful for the field. To this end, we sought to emulate the trans-synaptic spread of human tau in Drosophila melanogaster. Employing the trans-Tango circuit mapping technique, we investigated whether tau spreads between synaptically connected neurons. Immunohistochemistry and confocal imaging were used to look for tau propagation. Examination of hundreds of flies expressing four different human tau constructs in two distinct neuronal populations reveals a robust resistance in Drosophila to the trans-synaptic spread of human tau. This resistance persisted in lines with concurrent expression of amyloid-β, in lines with global human tau knock-in to provide a template for human tau in downstream neurons, and with manipulations of temperature. These negative data are important for the field as we establish that Drosophila expressing human tau in subsets of neurons are unlikely to be useful to perform screens to find mechanisms to reduce the trans-synaptic spread of tau. The inherent resistance observed in Drosophila may serve as a valuable clue, offering insights into strategies for impeding tau spread in future studies.
Keywords: Alzheimer’s disease; Drosophila melanogaster; neurodegeneration; tau; trans-synaptic.
© The Author(s) 2024. Published by Oxford University Press on behalf of the Guarantors of Brain.
Conflict of interest statement
T.L.S.-J. is the founding editor of Brain Communications. She had no involvement in the review process of this submission. T.L.S.-J. is on the scientific advisory boards of Cognition Therapeutics and Scottish Brain Sciences. P.V. is the scientific founder of Jay Therapeutics. None had any involvement in the current work.
Figures
References
-
- Tzioras M, McGeachan RI, Durrant CS, Spires-Jones TL. Synaptic degeneration in Alzheimer disease. Nat Rev Neurol. 2023;19(1):19–38. - PubMed
-
- Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 1991;82(4):239–259. - PubMed
-
- Oh M, Oh SJ, Lee SJ, et al. One-year longitudinal changes in tau accumulation on [18F]PI-2620 PET in the Alzheimer spectrum. J Nucl Med. 2024;65(3):453–461. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Molecular Biology Databases